Literature DB >> 33155324

Pandemic diseases preparedness and response in the age of COVID-19-a symposium report.

Jennifer Cable1, David L Heymann2, Amra Uzicanin3, Oyewale Tomori4, Maria Julia Marinissen5, Rebecca Katz6, Larry Kerr7, Nicole Lurie8, Gerald W Parker9, Syra Madad10,11, Beth Maldin Morgenthau12, Michael T Osterholm13, Luciana Borio14.   

Abstract

For years, experts have warned that a global pandemic was only a matter of time. Indeed, over the past two decades, several outbreaks and pandemics, from SARS to Ebola, have tested our ability to respond to a disease threat and provided the opportunity to refine our preparedness systems. However, when a novel coronavirus with human-to-human transmissibility emerged in China in 2019, many of these systems were found lacking. From international disputes over data and resources to individual disagreements over the effectiveness of facemasks, the COVID-19 pandemic has revealed several vulnerabilities. As of early November 2020, the WHO has confirmed over 46 million cases and 1.2 million deaths worldwide. While the world will likely be reeling from the effects of COVID-19 for months, and perhaps years, to come, one key question must be asked, How can we do better next time? This report summarizes views of experts from around the world on how lessons from past pandemics have shaped our current disease preparedness and response efforts, and how the COVID-19 pandemic may offer an opportunity to reinvent public health and healthcare systems to be more robust the next time a major challenge appears.
© 2020 New York Academy of Sciences.

Entities:  

Keywords:  COVID-19; Ebola; SARS; influenza; pandemic; pandemic preparedness; public health

Mesh:

Year:  2020        PMID: 33155324     DOI: 10.1111/nyas.14534

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Perceptions of COVID-19 vaccines among osteopathic medical students (OMS).

Authors:  Taysir Al Janabi; Ravi Chinsky; Maria A Pino
Journal:  Int J Osteopath Med       Date:  2021-11-02       Impact factor: 2.149

2.  Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab.

Authors:  Davide Allegrini; Raffaele Raimondi; Giovanni Montesano; Alfredo Borgia; Tania Sorrentino; Panagiotis Tsoutsanis; Mario R Romano
Journal:  Clin Ophthalmol       Date:  2021-10-08

Review 3.  Meanings and mechanisms of One Health partnerships: insights from a critical review of literature on cross-government collaborations.

Authors:  Syed Shahid Abbas; Tim Shorten; Jonathan Rushton
Journal:  Health Policy Plan       Date:  2022-03-04       Impact factor: 3.344

Review 4.  The Factors Influencing Public Satisfaction with Community Services for COVID-19: Evidence from a Highly Educated Community in Beijing.

Authors:  Qihui Xie; Xun Xie; Siwei Guo
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.